Data_Sheet_1_Effects of ambient temperature on influenza-like illness: A multicity analysis in Shandong Province, China, 2014–2017.docx by Jia Yin (287896)

“…The risk of ILI increased with decreasing weekly ambient temperature at the provincial level, and the effect was statistically significant when the temperature was <-1.5°C (RR = 1.24, 95% CI: 1.00–1.54). …”

DataSheet_2_A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal Cancer.pdf by Mahnoor Naseer Gondal (11145900)

“…Follow-on therapeutic screening of six colorectal cancer patients from cBioPortal using this drug combination demonstrated a 100% increase in apoptosis and a 100% decrease in proliferation. …”

DataSheet_1_A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal Cancer.zip by Mahnoor Naseer Gondal (11145900)

“…Follow-on therapeutic screening of six colorectal cancer patients from cBioPortal using this drug combination demonstrated a 100% increase in apoptosis and a 100% decrease in proliferation. …”

Supplementary Material for: Cardiorenal Outcomes With Finerenone in Asian Patients With Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD Post Hoc Analysis by Koya D. (16817664)

“…Efficacy outcomes included a primary kidney composite (time to kidney failure, sustained decrease of ≥40% in eGFR from baseline, and death from renal causes) and secondary cardiovascular (time to cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for heart failure) and kidney (time to kidney failure, sustained decrease of ≥57% in eGFR from baseline, and death from renal causes) composites. …”

Supplementary Material for: Cardiorenal Outcomes With Finerenone in Asian Patients With Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD Post Hoc Analysis by Koya D. (16817664)

“…Efficacy outcomes included a primary kidney composite (time to kidney failure, sustained decrease of ≥40% in eGFR from baseline, and death from renal causes) and secondary cardiovascular (time to cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for heart failure) and kidney (time to kidney failure, sustained decrease of ≥57% in eGFR from baseline, and death from renal causes) composites. …”

Supplementary Material for: Cardiorenal Outcomes With Finerenone in Asian Patients With Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD Post Hoc Analysis by Koya D. (16817664)

“…Efficacy outcomes included a primary kidney composite (time to kidney failure, sustained decrease of ≥40% in eGFR from baseline, and death from renal causes) and secondary cardiovascular (time to cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for heart failure) and kidney (time to kidney failure, sustained decrease of ≥57% in eGFR from baseline, and death from renal causes) composites. …”

Seedling and hairy roots of <i>Echinacea purpurea.</i> by Samane Khalili (21560106)

“…This study employed a hairy roots (HRs) culture and an elicitation system to enhance the production of chicoric acid in <i>E. purpurea</i>. HRs cultures were established, and different concentrations (0, 1.25, 2.5, 5, and 10% <i>v/v</i>) of elicitors derived from <i>Piriformospora indica</i> culture filtrate (CF) and cell extract (CE) were added at two time points during the HRs growth period (on days 24 and 26). …”

<i>Piriformospora indica</i> in PDB medium. by Samane Khalili (21560106)

“…This study employed a hairy roots (HRs) culture and an elicitation system to enhance the production of chicoric acid in <i>E. purpurea</i>. HRs cultures were established, and different concentrations (0, 1.25, 2.5, 5, and 10% <i>v/v</i>) of elicitors derived from <i>Piriformospora indica</i> culture filtrate (CF) and cell extract (CE) were added at two time points during the HRs growth period (on days 24 and 26). …”

DataSheet_1_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

“…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”

DataSheet_2_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

“…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”

Image_2_Ozone control as a novel method to improve health-promoting bioactive compounds in red leaf lettuce (Lactuca sativa L.).tif by Jin-Hui Lee (11865851)

“…The expression of most genes in lettuce plants exposed to 100 and 200 ppb of ozone increased rapidly after 0.5 h and showed a decreasing trend after reaching a peak. …”

Image_1_Ozone control as a novel method to improve health-promoting bioactive compounds in red leaf lettuce (Lactuca sativa L.).tif by Jin-Hui Lee (11865851)

“…The expression of most genes in lettuce plants exposed to 100 and 200 ppb of ozone increased rapidly after 0.5 h and showed a decreasing trend after reaching a peak. …”

The diagonal motion-based prediction (dMBP) model accounts for the Flash-lag effect. by Mina A. Khoei (3709270)

“…<p>(A) We plot the histogram of estimated positions from the dMBP model with a neural delay <i>τ</i> = 100 ms for the moving and the flashed stimuli. …”

Bone-related serum chemistry endpoints: Aquamin (180-day treatment group) versus placebo. by Muhammad N. Aslam (6598001)

Supplementary Material for: Overweight and Obesity in the Russian Population: Prevalence in Adults and Association with Socioeconomic Parameters and Cardiovascular Risk Factors by Kontsevaya A. (6431840)

“…Participants with obesity were more likely to have BP > 160/100 mm Hg (odds ratio > 2.0) and also > 140/90 mm Hg, raised blood glucose, and high triglycerides. …”

Combined epidural-general anesthesia was associated with lower risk of postoperative complications in patients undergoing open abdominal surgery for pheochromocytoma: A retrospecti... by Nan Li (155066)

“…</p><p>Methods</p><p>This was a retrospective cohort study. 146 patients who underwent open surgery for pheochromocytoma (100 received combined epidural-general anesthesia and 46 received general anesthesia) in Peking University First Hospital from January 1, 2002 to December 31, 2015 were enrolled. …”

Data_Sheet_1_Strict forest protection: A meaningful contribution to Climate-Smart Forestry? An evaluation of temporal trends in the carbon balance of unmanaged forests in Germany.d... by Rouven Nagel (7071380)

“…We analyzed a set of 64 forest sites, covering wide gradients of time since abandonment (0–68 years) and stand age (65–261 years) in even-aged, unmanaged beech forests. …”

Data_Sheet_1_A Scoping Review Exploring Whether a Free “Offer” Devalues or Widens Sport and Physical Activity Participation Amongst Children and Young Adults Aged 0–25?.pdf by E. J. Durden-Myers (12526672)

datasheet1_Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.docx by Yue Sun (197395)

“…As for the subgroup analysis, compared with 0.5 mg ozanimod, 1 mg ozanimod is related with a significant reduction of the annualized relapse rate during the treatment period (1 mg ozanimod, 0.18; 0.5 mg ozanimod, 0.24; RR, 0.05 [95% CI, 0.01, 0.09])and a decreased number of new or enlarging T2 lesions over the treatment period (1 mg ozanimod,1.58; 0.5 mg ozanimod, 2.05; RR, 0.49 [95% CI, 0.19, 0.79]). …”

datasheet1_Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.docx by Yue Sun (197395)

“…As for the subgroup analysis, compared with 0.5 mg ozanimod, 1 mg ozanimod is related with a significant reduction of the annualized relapse rate during the treatment period (1 mg ozanimod, 0.18; 0.5 mg ozanimod, 0.24; RR, 0.05 [95% CI, 0.01, 0.09])and a decreased number of new or enlarging T2 lesions over the treatment period (1 mg ozanimod,1.58; 0.5 mg ozanimod, 2.05; RR, 0.49 [95% CI, 0.19, 0.79]). …”